Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Drug Safety Update, Issue 12

The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update Issue 11 (PDF).

This issue includes the following drug safety advice articles:

  • Varenicline: suicidal thoughts and behaviour
  • Bisphosphonates: atrial fibrillation

In addition, this issue contains a hot topic containing information about
inhaled products that contain corticosteroids. This section contains several reminders for clinicians including consideration of the licensed indication for steroid inhalers, spacer devices and brand name prescribing for CFC-free beclometasone.

Action: Clinicians will find this publication to be a useful review of current issues in drug safety.

Share 'Drug Safety Update, Issue 12' on Email Share 'Drug Safety Update, Issue 12' on Delicious Share 'Drug Safety Update, Issue 12' on Digg Share 'Drug Safety Update, Issue 12' on Facebook Share 'Drug Safety Update, Issue 12' on Google+ Share 'Drug Safety Update, Issue 12' on reddit Share 'Drug Safety Update, Issue 12' on StumbleUpon Share 'Drug Safety Update, Issue 12' on Twitter

atomic-wealth

No Comments to “Drug Safety Update, Issue 12”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,320 spam comments.

atomic-wealth
fond-illness
summer